Perkasie, Penna. – January 28, 2014– Secant Medical has announced the availability of two diverse products that can advance the research and product development needs of medical device OEMs. The company is launching an off-the-shelf low-profile fabric for next-generation EVAR or heart valve component design and Regenerez™, a research-grade resin for tissue engineering applications. Both products will be on display at MD&M West, Anaheim, CA, at booth #1765 from February 11–13, 2014.
Low-Profile Option
“Available in eight different varieties, our woven low-profile fabrics offer clients an economical entrance into the market,” said Dan Treusch, business manager at Secant Medical. “Accessible through quick ship delivery, this product can help streamline our client’s development process.” Biocompatibility, low-permeability, high burst strength, and compaction for MIS delivery are a few of the features and benefits of the low-profile woven fabric.
Regenerez, A Regenerative Medicine Platform
“Regenerez, our research-grade biomaterial, is a bioresorbable elastomer platform for regenerative medicine. It has tunable mechanical properties and enables healing without creating a harmful immune response,” said Dr. Josh Simon, business development manager at Secant Medical. “The material’s flexibility and inherent elastomeric properties offer limitless possibilities for tissue engineering in a variety of in vivo applications.”
Secant Medical’s technical experts will have samples and additional data on Regenerezand the low-profile fabricat MD&M West. Visit the company’s booth to learn more about how these enhanced technologies can benefit device component design.
About MD&M West:MD&M West is a premier resource for the medical device industry, offering access to new technologies, world-class suppliers and expertise, updates on recent research and commercialization, and services for every aspect of the medical product development process.
About Secant Medical:Secant Medical provides advanced biomaterials and biomedical textile structures to the medical device industry. We partner with clients to design, develop, and manufacture high-performance biomedical structures for applications in cardiovascular, neurovascular, orthopedic and general surgery. Built on a 70-year history, we’re committed to the future of regenerative medicine and actively engage in research partnerships to advance next-generation biomaterial technology into practical applications for the medical device and pharmaceutical industries. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, contact Maria Fontanazza at 215-257-8680 x2192 or [email protected]; or visit www.secantmedical.com.